Health Research Ethics Board of Alberta – List of Members
HREBA membership as of 16 May 2023.
| Name | Board | TCPS 2 Roles & Specialties | Sex | City | ||||
| Lauren Birks, PhD | Cancer Committee | Community Member (Population and Public Health) | F | Calgary | ||||
| Ellen Burgess, MD | Cancer Committee | Scientific / Ethics (Nephrology / Pediatrics / Ethics) | F | Calgary | ||||
| Karen Campbell, | Cancer Committee | Community Member | F | Edmonton | ||||
| Brett Clelland, JD | Community Health Committee (Vice-Chair) | Law (Intellectual Property) | M | Edmonton | ||||
| Cheryl Currie, PhD | Clinical Trials Committee Community Health Committee |
Scientific (Quantitative / Qualitative methodology, including research involving Indigenous peoples and communities) | F | Lethbridge | ||||
| Sambasivarao Damaraju, PhD | Cancer Committee | Scientific (Cancer Genetics / Pharmacogenetics / Precision Medicine) | M | Edmonton | ||||
| Brenda Davis, LLM | Cancer Committee
Clinical Trials Committee (Chair) |
Privacy / Law | F | Edmonton | ||||
| Sunil Desai, MD | Cancer Committee Clinical Trials Committee (Vice Chair) |
Scientific (Pediatric Hematology / Oncology) | M | Edmonton | ||||
| Ann Marie Dewhurst, PhD | Clinical Trials Committee | Non-Scientific (Ethics) | F | Edmonton | ||||
| Dale Dewhurst, LLM, JD | Cancer Committee (Chair) | Ethics / Law (Virtue Ethics / Access to Justice) | M | Edmonton | ||||
| Katherine Duthie, PhD | Cancer Committee | Ethics (Clinical Ethics) | F | Edmonton | ||||
| Alysa Fairchild, MD, FRCPC | Cancer Committee | Scientific (Radiation Oncology) | F | Edmonton | ||||
| Xiangning Fan, MD | Clinical Trials Committee | Scientific (Occupational Medicine) | F | Edmonton | ||||
| David Fenton, MD, FRCPC | Cancer Committee | Scientific (Medical Oncology) | M | Edmonton | ||||
| Carlos Flores-Mir, MD | Clinical Trials Committee | Scientific (Dental) | M | Edmonton | ||||
| Sunita Ghosh, PhD | Cancer Committee | Scientific (Biostatistics) | F | Edmonton | ||||
| Allen Habib, PhD | Community Health Committee | Ethics (Philosophy) | M | Calgary | ||||
| Desiree Hao, MD | Cancer Committee | Scientific (Medical Oncology) | F | Calgary | ||||
| Joanne Hewitt, PhD | Cancer Committee | Scientific (Advanced Practice Nursing) | F | St. Albert | ||||
| Eve Hildebrand, BA | Cancer Committee | Community Member | F | Edmonton | ||||
| Lloyd Jamie Hodge, P.Eng. | Cancer Committee Community Health Committee |
Community Member | M | Calgary | ||||
| Megan Hogendoorn, JD | Community Health Committee | Law | F | Edmonton | ||||
| Sandra Johansen, PhD | Community Health Committee | Scientific (Methodologist) | F | Calgary | ||||
| Cyne Johnston, PhD | Community Health Committee (Chair) | Scientific (Qualitative / Mixed Methodology) | F | Calgary | ||||
| John Kennedy, MD, FRCPC | Clinical Trials Committee | Scientific (Psychiatry / Geriatrics / Neuropsychopharmacology) | M | Lethbridge | ||||
| Yume Kobayashi, BN | Clinical Trials Committee | Scientific (Nursing) | F | Edmonton | ||||
| Richard Lee-Ying, MD | Cancer Committee | Scientific (Medical Oncology) | M | Calgary | ||||
| Debbie Mallett | Clinical Trials Committee Community Health Committee | Community Member | F | Edmonton | ||||
| Mary Marshall, LLM | Cancer Committee | Privacy / Law | F | Edmonton | ||||
| Chris McTavish, PhD | Cancer Committee | Scientific (Ethics) | M | Edmonton | ||||
| Albert Mehl, MD | Clinical Trials Committee | Scientific (Pediatrics) | M | Black Diamond | ||||
| Beverley O’Brien, PhD | Cancer Committee | Ethics (Nursing) | F | Edmonton | ||||
| Jodi Parrotta, MA, CCRP | Clinical Trials Committee | Non-Scientific (Regulations) | F | Edmonton | ||||
| Nimesh Patel, MPH | Clinical Trials Committee Community Health Committee |
Scientific (Quantitative Methodology) | M | Lethbridge | ||||
| Robert Pearcey, MD | Cancer Committee | Scientific (Radiation Oncology) | M | Edmonton | ||||
| Guy Pelletier, PhD | Cancer Committee | Scientific (Psychosocial Oncology) | M | Calgary | ||||
| Neelan Pillay, MB.ChB. | Clinical Trials Committee | Scientific (Neurology) | M | Calgary | ||||
| Azadeh Nikoo Rajaee, MD, MHE, FRCSC | Clinical Trials Committee | Scientific (MD, General Surgery) | F | Edmonton | ||||
| Loralee Robertson, BSc, MLT Dipl. |
Clinical Trials Committee | Community Member | F | Calgary | ||||
| Gloria Roldán Urgoiti, MD, FRCPC | Cancer Committee | Scientific (Medical Oncology) | F | Calgary | ||||
| Mary-Pat Schlosser, MD | Cancer Committee | Scientific (Pediatric Palliative Care) | F | Edmonton | ||||
| Fiona Schulte, PhD | Cancer Committee | Scientific (Pediatric Psychosocial Oncology) | F | Calgary | ||||
| Christopher Sikora, MD | Community Health Committee | Scientific (Physician) | M | Edmonton | ||||
| Michael Smylie, MD | Cancer Committee | Scientific (Medical Oncology) | M | Edmonton | ||||
| Keith Tankel, MD | Cancer Committee | Scientific (Radiation Oncology) | M | Edmonton | ||||
| Andrew Robert Turner, MD | Cancer Committee | Scientific (Medical Oncology / Hematology) | M | Edmonton | ||||
| Joan Turner, PhD | Clinical Trials Committee | Scientific (Oncology, DNA repair/ Genetics, Radiation Biology) | F | Edmonton | ||||
| Raul Urtasun, MD | Cancer Committee (Vice Chair) | Scientific (Radiation Oncology) | M | Edmonton | ||||
| T. Edward Vant (Ted), MD | Clinical Trials Committee | Scientific (Family Medicine) | M | Calgary | ||||
| Brent Windwick, QC, LLM | Cancer Committee Clinical Trials Committee |
Law (Health Law) | M | Edmonton | ||||
| Jackson Wu, MD | Cancer Committee (Vice Chair) | Scientific (Radiation Oncology) | M | Calgary | ||||
| Xiaofu Zhu, MD | Cancer Committee | Scientific (Medical Oncology) | M | Edmonton |
The HIA-designated Health Research Ethics Board of Alberta consists of three committees [the Cancer Committee (CC), Clinical Trials Committee (CTC), and Community Health Committee (CHC)] operating as one Research Ethics Board. As such, members from one committee may attend another committee’s meeting when their expertise is required. This ensures that members in attendance have the specific expertise, relevant competence and knowledge necessary to provide an adequate research ethics review of the proposals under consideration.
The majority of the members are Canadian citizens or permanent residents under the Immigration and Refugee Protection Act. HREBA is constituted and operates in accordance with the Alberta Health Information Act (HIA), the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS 2), Good Clinical Practice (GCP) Guidelines of the International Conference on Harmonization (ICH), Health Canada’s Food and Drug Regulations (FDR), Part C, Division 5 and is registered with the U.S. Department of Health and Human Services (HHS), Office for Human Research Protections (OHRP) where required.
Members named as Principal Investigators or Co-investigators on a study that is under review do not participate in discussions related to, nor vote on, such studies when they are presented; this applies to initial and continuing reviews.
A pdf version of this list, as well as previous lists of HREBA members, can be found here